HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leonardo Punzi Selected Research

leukocyte endogenous mediator

1/2017A Brief History of IL-1 and IL-1 Ra in Rheumatology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leonardo Punzi Research Topics

Disease

28Inflammation (Inflammations)
02/2022 - 10/2003
26Psoriatic Arthritis
09/2021 - 09/2007
22Osteoarthritis
09/2021 - 10/2004
16Pain (Aches)
03/2022 - 08/2002
16Arthritis (Polyarthritis)
03/2022 - 06/2005
16Rheumatoid Arthritis
09/2021 - 10/2008
13Ankylosing Spondylitis
01/2018 - 06/2005
11Gout
01/2020 - 08/2010
10Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2017 - 12/2004
8Joint Diseases (Joint Disease)
09/2021 - 02/2002
8Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
03/2017 - 01/2012
6Axial Spondyloarthritis
06/2020 - 07/2014
6Rheumatic Diseases (Rheumatism)
06/2020 - 07/2004
6Myositis (Idiopathic Inflammatory Myopathies)
01/2017 - 10/2012
5Infections
03/2022 - 11/2012
5Autoimmune Diseases (Autoimmune Disease)
11/2015 - 09/2014
5Synovitis
03/2013 - 01/2005
4Crystal Arthropathies
03/2022 - 10/2011
4Knee Osteoarthritis
12/2019 - 08/2011
4Fever (Fevers)
01/2017 - 05/2008
4Lupus Nephritis
11/2016 - 01/2013
4Necrosis
01/2016 - 04/2012
4Polymyositis
12/2015 - 10/2012
4Crohn Disease (Crohn's Disease)
07/2014 - 06/2005
3Blau syndrome
02/2022 - 06/2005
3Psoriasis (Pustulosis Palmaris et Plantaris)
09/2019 - 02/2018
3Wounds and Injuries (Trauma)
01/2019 - 01/2017
3Spondylarthropathies
01/2019 - 10/2005
3Disease Progression
12/2018 - 12/2013
3Spondylitis
12/2018 - 10/2007
3Hyperuricemia
01/2018 - 11/2012
3Adult-Onset Still's Disease
01/2017 - 01/2011
3Neoplasms (Cancer)
10/2016 - 06/2013
3Thrombosis (Thrombus)
11/2015 - 09/2014
3Congenital Abnormalities (Deformity)
12/2014 - 11/2011
3Dermatomyositis (Dermatopolymyositis)
06/2013 - 10/2012
2Acquired Immunodeficiency Syndrome (AIDS)
02/2022 - 11/2012
2Reactive Arthritis (Reiter Disease)
09/2021 - 05/2013
2Chondrocalcinosis (Pseudogout)
09/2020 - 10/2011
2Chronic Disease (Chronic Diseases)
03/2018 - 06/2014
2Sacroiliitis
01/2018 - 11/2017
2Fatigue
01/2018 - 11/2017
2Fibrosis (Cirrhosis)
01/2017 - 10/2015
2Proteinuria
01/2017 - 05/2016
2Chronic Kidney Failure (Chronic Renal Failure)
05/2016 - 12/2012

Drug/Important Bio-Agent (IBA)

16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2020 - 02/2002
14CytokinesIBA
02/2022 - 02/2002
13Uric Acid (Urate)IBA
09/2021 - 11/2012
13Etanercept (Enbrel)FDA Link
12/2018 - 07/2012
12AutoantibodiesIBA
02/2022 - 07/2004
12Biomarkers (Surrogate Marker)IBA
02/2022 - 10/2004
10Adalimumab (Humira)FDA Link
01/2018 - 12/2012
10AntibodiesIBA
11/2016 - 10/2012
9Proteins (Proteins, Gene)FDA Link
02/2022 - 10/2011
9Tumor Necrosis Factor InhibitorsIBA
06/2020 - 03/2011
8Calcium PyrophosphateIBA
03/2022 - 10/2011
8Infliximab (Remicade)FDA Link
01/2018 - 08/2009
8Pharmaceutical PreparationsIBA
11/2017 - 11/2012
76-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
03/2022 - 10/2011
7InterleukinsIBA
01/2017 - 02/2002
6Interleukin-6 (Interleukin 6)IBA
09/2019 - 02/2002
6ametantrone (HAQ)IBA
02/2018 - 12/2007
6Biological ProductsIBA
11/2016 - 08/2009
5SteroidsIBA
11/2020 - 09/2007
5Immunosuppressive Agents (Immunosuppressants)IBA
08/2018 - 07/2013
5C-Reactive ProteinIBA
02/2018 - 06/2010
5Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2017 - 05/2008
5EnzymesIBA
12/2015 - 10/2012
4CalciumIBA
01/2019 - 01/2013
4Antiphospholipid AntibodiesIBA
11/2015 - 01/2012
4InflammasomesIBA
05/2014 - 11/2012
4Ligases (Synthetase)IBA
08/2013 - 01/2013
3AntigensIBA
02/2022 - 02/2005
3ChemokinesIBA
02/2022 - 02/2006
3Metalloproteases (Metalloproteinases)IBA
07/2020 - 10/2003
3Xanthine OxidaseIBA
01/2018 - 08/2010
3Interleukin-1 (Interleukin 1)IBA
01/2017 - 11/2015
34-hexyloxyaniline (HOA)IBA
10/2016 - 06/2010
3Methotrexate (Mexate)FDA LinkGeneric
06/2016 - 07/2013
3Immunoglobulin M (IgM)IBA
11/2015 - 01/2013
3Rituximab (Mabthera)FDA Link
07/2015 - 07/2013
3AutoantigensIBA
01/2015 - 02/2013
3RNA (Ribonucleic Acid)IBA
07/2013 - 10/2012
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2013 - 05/2008
2VaccinesIBA
03/2022 - 05/2016
2PolyphenolsIBA
11/2019 - 03/2018
2AdipokinesIBA
09/2019 - 06/2014
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
03/2018 - 01/2013
2golimumabFDA Link
01/2018 - 11/2017
2Prednisone (Sone)FDA LinkGeneric
03/2017 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 05/2016
2Transforming Growth Factors (Transforming Growth Factor)IBA
10/2016 - 04/2012
2Complement System Proteins (Complement)IBA
05/2016 - 11/2011

Therapy/Procedure

30Therapeutics
11/2020 - 08/2002
3Mud Therapy (Mud Bath)
06/2020 - 10/2007
3Injections
06/2019 - 07/2012
3Plasma Exchange
12/2015 - 01/2012
2Biological Therapy
09/2020 - 05/2011
2Mediterranean Diet
12/2019 - 01/2015
2Baths
12/2018 - 10/2007